Sonendo, Inc.

OTCPK:SONX Stock Report

Market Cap: US$6.2m

Sonendo Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Sonendo.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth17.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Analysis Article • Nov 10

Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%

The latest analyst coverage could presage a bad day for Sonendo, Inc. ( NYSE:SONX ), with the analysts making...
Analysis Article • Apr 19

A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share Price

Sonendo, Inc.'s ( NYSE:SONX ) price-to-sales (or "P/S") ratio of 1.9x might make it look like a buy right now compared...
Seeking Alpha • Jan 04

Sonendo unit PIPStek files patent infringement lawsuit against Biolase

Dental technology company Sonendo (NYSE:SONX) on Wednesday said its unit PIPStek had filed a patent infringement lawsuit against maker of dental lasers Biolase (NASDAQ:BIOL). The lawsuit was filed by PIPStek in the U.S. District Court for the District of Delaware. "In the lawsuit, PIPStek asserts infringement of PIPStek’s US patents 11,426,239 and 11,350,993 by BIOLASE’s Waterlase laser," SONX said in a statement. SONX acquired PIPStek and all its intellectual property in 2017, including PIPStek's laser technologies for dental applications. Sonendo (SONX) stock earlier closed -10.2% at $2.03, while shares of Biolase (BIOL) ended +5.6% at $0.75.
Seeking Alpha • Nov 09

GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49M

press release (NYSE:SONX): Q3 GAAP EPS of -$0.47 misses by $0.08. Revenue of $9.8M (+24.1% Y/Y) beats by $0.49M. The Company expects full year 2022 total revenue to be in the range of $40.5 million to $42.5 million, vs $41.57M Consensus.
Seeking Alpha • Sep 23

Sonendo announces $63 million private placement

Sonendo (NYSE:SONX) announced a $63M private placement of common stock and pre-funded warrants. New and existing investors, including Pura Vida Investments, First Light Asset Management, Blue Water Life Science Advisors, ArrowMark Partners, Driehaus Capital Management, and JMR Capital participated in the financing. The securities purchase agreements entered into with the investors provide for the purchase of an aggregate of 23,045,536 shares of its common stock at a purchase price/share of $0.95, and pre-funded warrants to purchase an aggregate of 43,315,846 shares of common stock at a purchase price of $0.949/pre-funded warrant, through a private investment in public equity financing. The pre-funded warrants will have an exercise price of $0.001/share of common stock, be immediately exercisable and remain exercisable until exercised in full. The private placement is expected to close on or about September 27, 2022. The company intends to use the net proceeds from the financing to accelerate ongoing commercialization efforts and further expand its current product portfolio and for working capital as well as other general corporate purposes.
Seeking Alpha • Nov 07

Sonendo: Painful Debut For This Dental Play

Sonendo has gone public in an offering which has been a big disappointment as investors rightfully have concerns about growth and losses. I like the potential of the system, but as commercial traction is lagging with a huge market opportunity ahead, I am joining that cautious stance. The huge fall in the share price limits the potential to raise equity capital in a not too dilutive way in the coming quarters.

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sonendo has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:SONX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202432-34-25-25N/A
9/30/202442-37-31-31N/A
6/30/202442-47-38-37N/A
3/31/202442-57-41-40N/A
12/31/202335-62-47-46N/A
9/30/202338-62-52-51N/A
6/30/202340-60-57-56N/A
3/31/202341-57-62-60N/A
12/31/202242-57-62-61N/A
9/30/202239-60-63-62N/A
6/30/202237-57-57-56N/A
3/31/202235-53-56-54N/A
12/31/202133-48-51-49N/A
9/30/202132-47-43-42N/A
6/30/202130-45-41-39N/A
3/31/202127-46-41-40N/A
12/31/202023-47-39-39N/A
12/31/201935-49-53-49N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if SONX's forecast earnings growth is above the savings rate (3.7%).

Earnings vs Market: Insufficient data to determine if SONX's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if SONX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if SONX's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if SONX's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if SONX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 05:26
End of Day Share Price 2026/09/14 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sonendo, Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael ChernyBofA Global Research
Vadim MerkulovFreedom Broker
Ilya ZubkovFreedom Broker